View Full Version : General Cancer News
- U-Systems somo•v Automated Breast Ultrasound system granted FDA PMA approvable letter
- BI-RADS useful in predicting malignant breast lesions detected with MRI
- Cyclophosphamide drug makes the bone marrow more tumor-friendly
- Combination of vaccine and letrozole effectively improves survival from breast cancer
- CINJ prefers more personalized approach to prescribing cancer treatment
- Lecture discusses how negative emotions fuel cancer formation and metastasis
- Results from Boehringer Ingelheim’s LUX-Lung 3 Phase III trial on stage IIIB or IV NS
- Combination of daclizumab and vaccine improves survival of breast cancer patients
- NanoString commences second clinical study of PAM50-based breast cancer assay
- Project aims to find new diagnostic tools, drugs for triple negative breast cancer
- TJU researchers to investigate Cu-64 imaging agent for prostate cancer
- Apigenin effective against human breast cancer
- Breast cancer cell surface protein blows cover of potent tumor-generating cells
- Researchers sequence genomes of 21 breast cancers
- Study: No racial and ethnic disparities in preoperative breast cancer imaging
- Conservative group makes major ad buy to charge President Obama with using the health
- Breast cancer vaccine that elicits powerful immune response also improves recurrence
- Promising updates in quest for early detection and treatments for lung cancer
- Panobinostat able to target and destroy triple negative breast cancer
- HS6ST2 enzyme an important regulator of breast cancer cell-bone interactions
- Study shows how a drug-lead compound suppresses tumour formation
- Biomarker neutralizes effect of bevacizumab in pancreas and kidney cancer patients
- Deletion of 'lunatic fringe' promotes tumor formation of basal-like breast cancers
- HSF-1 protein likely source of chemotherapy-related heart damage in mice
- MRI provides early indication of breast tumor's response to pre-surgical chemotherapy
- Special feature of Science journal highlights protein array technology
- MCP enhances anti-cancer effects of two poly-botanical formulas
- New clinical trial to evaluate HSP90 inhibitor plus hormonal therapy for breast cance
- MTI develops SureTouch Wireless system for breast cancer screening
- Viewpoints: The promise and perils of prostate screening; Presidential candidates shy
- Preliminary results from Celldex’s CDX-011 Phase 2b breast cancer study
- Halo Healthcare acquires assets of NeoMatrix
- Poor cardio-pulmonary function may be strong predictor of survival in women with brea
- Researchers identify single gene that controls aging, inflammation and cancer
- Study says most insurance sold to individuals doesn't meet health law standards
- Thioridazine drug successfully kills human cancer stem cells
- Blocking Skp2 protein might inhibit glycolysis and treat breast cancer
- Increased risk of breast cancer associated with working night shifts
- Safety of breast implants
- Studies outline dilemmas on new generic heart drugs, hormone replacement therapy
- Overdiagnosis: harming the healthy
- Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC
- Pfizer’s XALKORI now available in Canada
- TAU researcher develops new antibodies to target and destroy cancer cells
- GE to provide attendees with overview of new oncology solutions at ASCO annual meetin
- Simple blood test can detect genetic faults in patients with cancer
- Researchers develop special brassiere for breast cancer patients
- Kindstar, Insight Genetics collaborate to improve cancer care in China
- Scientists succeed in solving first structure of a Wnt protein
- Personalized medicine and the Human Genome Project
- Researchers discover binding partner of TDF hormone
- Montefiore experts available to discuss cancer research at 2012 ASCO meeting
- America's biopharmaceutical researchers work on many new approaches to fight cancer
- Agendia launches ColoPrint microarray-based 18-gene expression signature for colon ca
- 'Atzelberg Circle' researchers meet to advance hyperthermia as standard combination c
- UH CNRCS students achieve significant milestones in cancer therapy research
- Studies support diagnostic utility of molecular classification in difficult-to-diagno
- Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory
- Study reveals why GBM is highly resistant to current chemotherapies
- Avastin (bevacizumab)-induced tumor calcifications can be elicited in glioblastoma
- Roche to initiate three studies with T-DM1 for early stage HER2-positive breast cance
- Affibody, GE Healthcare partner to develop Her2-targeted PET imaging agent
- Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint
- Variation in microRNAs may explain survival differences in breast cancer
- Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting
- Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer
- Results from Puma’s PB272 Phase I combination trial on metastatic HER-2 positive brea
- ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast
- New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors
- Androgen receptor an additional hormonal target in many breast cancers
- Caffeine/coffee intake associated with reduced risk of dementia or delayed onset
- Researchers uncover cellular basis for age-related breast cancer vulnerability
- Alnylam announces results from ALN-VSP Phase I study on liver cancers
- High doses of ginseng more effectively reduce cancer-related fatigue in patients
- Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancrea
- Preoperative breast cancer pain involves an inflammatory process
- Study detects significant changes in the EEG brain activity patterns during chemother
- T-DM1 better than standard therapy in controlling breast cancer
- New immune response data from Generex’s AE37 Phase II trial on breast cancer
- bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients
- Cardio-protective drug during cancer treatment may prevent heart damage in children
- Better diagnosis of breast cancer could come from simple blood test
- Work pattern affects night shift–breast cancer link
- CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing
- Debiopharm announces results from Debio 0932 Phase I study on cancer
- New data supports clinical role of Cambridge Heart’s MTWA test in managing patients a
- Genentech receives FDA approval for Perjeta to treat HER2-positive metastatic breast
- ADAM28 inhibits VWF-mediated cancer cell apoptosis and enhances lung metastases
- BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD
- Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy
- Investigational drug slows metastatic breast cancer progression
- ColoPrint aids prediction of colorectal cancer relapse
- Premature cancer death risk may be increased by dental plaque
- Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective
- Unnecessary medical imaging can reduce risk of breast cancer in women
- Study investigates how breast cancer cells migrate to bone
- Study reveals molecular link between aging and cancer
- Variations in microRNA expression within breast tumors can lead to sampling bias
- CINJ commences enrollment in three-drug combination trial for breast cancer
- In Calif. and Mass., reforms proceeding even as court causes uncertainty
- Bisphosphonate benefit for breast cancer yet to be proven
- Inserm researchers examine effect of night work on women’s health
- Value of pathology review highlighted in node-negative breast cancer
- New robotic device can improve detection of breast cancer
- Review describes new classes of drugs that target androgens in novel ways
- GBM patients with CNP subtype may have less aggressive subtype of cancer
- Novel small-molecule-inhibiting drug stops spread of breast cancer cells
- FDA advisory panel issues positive opinion for Dune's MarginProbe System
- Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live lon
- New paper discusses potential of tumor-derived microvesicles
- Deferasirox reduces elevated iron levels in patients with myelodysplastic syndrome
- Physical activity linked with reduced risk of breast cancer
- Amgen launches Chemotherapy: Myths or Facts campaign for cancer patients
- LLUMC suggests check list with six key attributes for successful proton therapy treat
- p53 protein may show a typical prion-like behavior when mutated
- Cancer survivors benefit from healthy lifestyle
- Experimental medication increases muscle strength in cancer patients with low testost
- Metformin reduces overall cancer risk in patients with Type 2 diabetes
- Report on the global market for breast cancer diagnostics and drug technologies
- Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung
- Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma
- Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulth
- GUMC receives NIH grant to establish Center of Excellence for Health Disparities
- Decline in preventive mammography rates after USPSTF recommendation
- ‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed
- ‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed
- Study examines role and biological effects of psychotherapy in breast cancer survivor
- ACR updates 39 appropriateness criteria topics and adds five new criteria
- Flexible wearable antenna system for breast tumor detection
- Shorter regimen of radiotherapy safe for noninvasive breast cancer patients
- Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012
- Shots to the heart ‘not risky’
- Study demonstrates effectiveness of combination therapy for breast cancer cells in vi
- Imaging PR status may help identify tumor response to endocrine therapy
- GRP78 play an important role in breast cancers that respond to anti-estrogen therapy
- PGD for breast cancer genes BRCA1/2 is now feasible
- NOTCH1 signaling promotes T-cell acute lymphoblastic leukemia-initiating cell regener
- 23andMe identifies seven SNPs associated with breast size
- Former President Bush in Zambia, Botswana to promote Pink Ribbon Red Ribbon initiativ
- Italy's first successful pregnancy and delivery following transplantation of ovarian
- Single dose breast cancer treatment helps forego 6-7 week radiation regimen
- Scientists identify causative link between oncometabolite and onset of AML
- Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin
- The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO gra
- Insight into understanding IDH mediated disease
- NewYork-Presbyterian/WCMC first in N.Y. City to offer INTRABEAM radiotherapy
- New optical microscope identifies rare breast cancer cells
- Study determines risk of young-onset breast cancer after use of ovulation-stimulating
- Hormone therapy still an acceptable treatment for menopausal symptoms: New joint stat
- Protein interactions outside breast cancer cells can permanently stop proliferation
- MammaPrint more cost-effective and clinically-useful test than Oncotype DX
- RA patients do not receive fewer cancer screening tests than general population: Stud
- Scientists develop novel anticancer drug designed to travel through the bloodstream
- Biomarkers predict benefit of targeted therapy in metastatic renal-cell cancer
- Book explains complex world of personalized medicine
- New approach integrates rational drug design with supramolecular nanochemistry in can
- Breast cancer dug bevacizumab slows progression but has no overall survival benefit
- Prenatal and early childhood exposure to PCE may be associated with long-term visual
- New assay can identify rare cancerous cells within mixed populations
- Low-fat, high fruit and vegetable diet may help reduce menopausal symptoms
- Nutrisystem announces debut of enhanced weight management plan for people with diabet
- Breast cancer patients who undergo breast conserving surgery often have a reoperation
- Patient interaction with medical record boosts prevention service use
- Rheumatoid arthritis patients take-up cancer screening
- Ampio announces advancement of NCE001 to preclinical development
- Lack of physical activity causes 1 in 10 deaths
- New roadmap provides expert guidance on how to reduce racial and ethnic health dispar
- Cancer more likely in people with serious mental illnesses
- People with schizophrenia more likely to develop cancer
- Researchers discover potential drug targets that might reduce ventilator-induced lung
- HAS-BLED: Atrial fibrillation patients undergoing angioplasty can still take anticoag
- Ablation technique destroys eye of the storm
- A world of consequences due to physical inactivity
- Unsuccessful fertility treatment reduces young-onset breast cancer risk
- Breast-conserving surgery carries high reoperation risk
- Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer
- Researchers discover reason why breast cancer cells become drug resistant
- International Congress on Natural Products Research to be held in New York City
- First Edition: July 23, 2012
- AF deaths more likely on the weekend
- Fat grafts ‘safe’ following breast reconstruction
- SUMEC to distribute Aurora's breast MRI technology in China
- Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia
- HALO, UND enter agreement to develop biomarkers for early detection of breast cancer
- Queen's University, Cirdan Imaging partner to develop novel techniques for cancer det
- RhoC gene promotes breast cancer stem cell progression
- Daily Beast profiles George W. Bush's post-presidency global health work
- EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer
- Constant pain after breast cancer surgery ‘more taxing’
- Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cel
- Study investigates molecular markers in drug-resistant ovarian cancer
- Lack of physical activity and life expectancy: an interview with Dr I-Min Lee
- Study sheds light on complexities of cancer genetics
- EPHA3 mutations may be important drivers of lung cancers
- TAU researcher reveals link between plant and human biology
- Researchers use computational analysis to identify new Achilles heel for drug-resista
- Rye Radiology offers new 3D mammography that detects many breast cancers
- Scientists discover novel therapeutic target for advanced breast cancer
- Researchers discover new approach to treat two lethal metastatic cancers
- Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner
- First Edition: August 1, 2012
- APA Convention to highlight new research in personality and social psychology
- MLK3 protein critical driver of breast cancer cell migration and invasion
- High maternal choline intake may reduce risk of hypertension and diabetes in babies
- In rare compromise, Hill leaders agree on temporary spending deal to keep government
- Combination of anastrozole and fulvestrant extends survival in women with metastatic
- Study looks at hope experience of male spouses of breast cancer patients
- Combination hormonal therapy improves survival in advanced breast cancer
- Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients
- Mammography oversold by breast cancer charity
- HSF1 increases expression of chaperones and supports cancer metastasis
- Sta Op Tegen Kanker International Translational Cancer Research Grant recipients anno
- Komen ads overstate benefits of mammograms, professors charge
- New sequencing approach can provide more effective method of BRCA1/2 mutational analy
- Montefiore launches first fellowship program in Women's Physical Medicine and Rehabil
- Human-derived breast cancer xenografts allow revolution in individualized cancer care
- ‘Chicken Wing’ clue to stroke risk in atrial fibrillation
- Clinical trial targets breast cancer cells by injecting trastuzumab directly into the
- New class of drugs reduces adverse effects of cellular damage from cancer chemotherap
- New research hopes to uncover mystery behind breast cancer metastasis
- Clovis Oncology reports net loss of $15.7 million for second quarter 2012
- GTx reports revenue of $1.6 million for second quarter 2012
- Old cardiac drug performs new tricks
- Inaugural event of National Women's Survivors Convention to be held in Nashville
- MedPage Today, CollabRx sign license agreement for Oncology Next
- Herceptin® could potentially be delivered via a standard injection
- Female voters are hot commodity for presidential candidates
- Combination therapy delays progression for metastatic breast cancer patients
- Fat transfers may benefit patients after breast reconstructive surgery
- Highlights: New reports of problems at Parkland Hospital in Dallas; Mammogram rates d
- Radiation after lumpectomy helps prevent need for subsequent mastectomy in older wome
- Radiation therapy following lumpectomy may benefit older, early-stage breast cancer p
- State roundup: Fla. groups ask Gov. for essential benefits hearings
- Springer to publish book series in cooperation with The Breast Cancer Research Founda
- Novel method identifies new oncogene that contributes to development of cancer
- HAS-BLED proves predictive ability
- Early stage breast cancer in older women: an interview with Dr. Benjamin Smith
- Viewpoints: Romney needs to explain his Medicare plan; Ryan plan would end Medicaid p
- Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professo
- Radiosensitivity molecular signature can lead to better radiation therapy decisions f
- Pregnant women who undergo chemotherapy do not appear to increase their baby’s risk o
- Research examines racial and ethnic differences in strokes
- Peptide combinations might offer more effective cancer therapy
- Study examines whether eribulin offers added benefit to women with breast cancer
- Anti-cancer regimens with multiple modes of action increase treatment effectiveness
- Lack of certain gene occurs in almost 28% of breast cancers
- Viewpoints: Insuring medical treatments are well researched; GOP Govs reluctance on e
- Mayo Clinic receives approval for construction of new building on Phoenix campus
- Higher mammographic density not linked to reduced survival in breast cancer patients
- First Edition: August 21, 2012
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.